Updates are available Correction dated 2024-02-28
Click to view Correction: https://doi.org/10.1007/s40271-024-00682-x
-
Authors
Shaw, Caroline https://orcid.org/0009-0006-2944-4715
Longworth, Louise https://orcid.org/0000-0003-2512-4862
Bennett, Bryan
McEntee-Richardson, Louise
Shaw, James W.
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb
- License Information
-
More Information
Article History
Accepted: 19 November 2023
First Online: 12 December 2023
Change Date: 28 February 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40271-024-00682-x
Declarations
:
: This study was funded by Bristol Myers Squibb.
: Drs C Shaw, Longworth and McEntee-Richardson are employees of Putnam, UK, which provides research services to pharmaceutical companies. Dr Bennett was employed by Bristol Myers Squibb, UK at the time this research was conducted. Dr JW Shaw is employed by and reports stock ownership in Bristol Myers Squibb, USA. Drs JW Shaw and Longworth are members of the EuroQol group, a not-for-profit group that developed and distributes the EQ-5D.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Caroline Shaw: Methodology, investigation, formal analysis, data curation, writing – original draft, writing – review and editing, visualisation and project administration; Louise Longworth: conceptualisation, methodology, formal analysis, methodology, formal analysis, data curation, writing – original draft, writing – review and editing, visualisation and supervision; Bryan Bennett: conceptualisation, methodology, writing – review and editing and supervision; Louise McEntee-Richardson: investigation, formal analysis, data curation, writing – original draft, writing – review and editing and visualisation; and James W. Shaw: conceptualisation, methodology, writing – review and editing and supervision.
